Position in LLY
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$6,389,364
+$2,775,588 QoQ
Shares Held
5,327
+35.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.68%
of 13F equity value
Holder Rank
#1,531
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 18%
Shared 0%
None 82%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Csenge Advisory Group holds $34,699,600 across 10 Drug Manufacturers - General names. LLY ranks #1 (18.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
5,327 | $6,389,364 | |
| 2 | ABBV |
AbbVie Inc.
|
25,158 | $6,330,759 | |
| 3 | JNJ |
Johnson & Johnson
|
18,196 | $4,621,238 | |
| 4 | AMGN |
Amgen Inc
|
10,362 | $3,752,287 | |
| 5 | PFE |
Pfizer Inc
|
154,984 | $3,732,014 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
22,416 | $2,832,037 | |
| 7 | NVS |
Novartis AG
|
16,110 | $2,524,759 | |
| 8 | GSK |
GSK plc
|
41,506 | $2,175,744 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,389,364 | 5,327 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $3,613,776 | 3,929 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $3,751,708 | 3,491 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $2,983,330 | 3,910 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $3,679,381 | 4,720 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $3,577,016 | 4,331 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $3,554,288 | 4,604 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $5,292,605 | 5,974 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $5,039,345 | 5,566 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $4,002,604 | 5,145 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $2,455,259 | 4,212 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $2,223,181 | 4,139 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $1,936,887 | 4,130 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $1,188,576 | 3,461 | Shares | Sole | 2023-05-01 | |
| 2022-12-31 | $1,271,294 | 3,475 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $1,304,717 | 4,035 | Shares | Sole | 2022-10-04 | |
| 2022-06-30 | $1,299,838 | 4,009 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $1,052,982 | 3,677 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $738,888 | 2,675 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,000,446 | 4,330 | Shares | Sole | 2021-10-20 | |
| 2021-06-30 | $613,966 | 2,675 | Shares | Sole | 2021-07-21 | |
| 2021-03-31 | $638,363 | 3,417 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $942,127 | 5,580 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $966,718 | 6,531 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $1,017,587 | 6,198 | Shares | Sole | 2020-07-17 | |
| 2020-03-31 | $537,956 | 3,878 | Shares | Sole | 2020-04-21 | |
| No filing history on record for this holder in this stock. | ||||||